Compare Target Corporation (TGT) vs Zimmer Biomet Holdings Inc (ZBH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Target Corporation vs Zimmer Biomet Holdings Inc — how do they compare? Target Corporation trades at $138.64 (market cap $63.40B), while Zimmer Biomet Holdings Inc trades at $90.03 (market cap $17.36B). The key difference: Target Corporation is far larger — about 3.7× Zimmer Biomet Holdings Inc's market cap, and Target Corporation pays the higher dividend (3.32%). Which is the better fit depends on your goals.
| TGT | ZBH | |
|---|---|---|
Market Cap | $63.40B | $17.36B |
Sector | Consumer Cyclical | Health |
52-Week High | $141.19 | $107.71 |
52-Week Low | $83.68 | $79.58 |
Enterprise Value | $78.70B | $24.40B |
Dividend Yield | 3.32% | 1.07% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Target Corporation
With 1,926 stores (as of the end of fiscal 2021), Target is a leading American general merchandise retailer, offering a variety of products across several categories, including beauty and household essentials (26% of fiscal 2021 sales), food and beverage (19%), home furnishings and décor (19%), hardlines (18%), and apparel and accessories (17%). Most of Target's stores are large, averaging more than 125,000 square feet. The company has a significant e-commerce presence, deriving around 19% of sales from the channel (up from about 9% in fiscal 2019, before the pandemic). In addition to its namesake stores, Target owns Shipt, an online same-day delivery platform. After it exited Canada in 2015, virtually all of Target's revenue is generated from the United States.
Read more on TGT →About Zimmer Biomet Holdings Inc
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly 70% of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, and related surgical products.
Read more on ZBH →
